股本结构
单位:万股
| 公告日期 | 2025-10-28 | 2025-07-17 | 2025-04-29 | 2025-01-31 | 2024-10-29 | 2024-07-18 |
|---|---|---|---|---|---|---|
| 证券总股本 | 191879.21 | 193585.32 | 195925.39 | 197508.92 | 199927.00 | 202457.92 |
| 普通股本 | 191879.21 | 193585.32 | 195925.39 | 197508.92 | 199927.00 | 202457.92 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
,当前存托凭证比例为:1
历史变动
| 公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-10-28 | 191879.21 | 未披露 | 定期报告 | 2025-09-30 |
| 2025-07-17 | 193585.32 | 未披露 | 定期报告 | 2025-06-30 |
| 2025-04-29 | 195925.39 | 未披露 | 定期报告 | 2025-03-31 |
| 2025-01-31 | 197508.92 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Shares acquired to be canceled
Other share purchases
Equity-based compensation plans, exercise of options and employee transactions
Other movements
|
2024-12-31 |
| 2024-10-29 | 199927.00 | 未披露 | 定期报告 | 2024-09-30 |
| 2024-07-18 | 202457.92 | 未披露 | 定期报告 | 2024-06-30 |
| 2024-04-23 | 204040.64 | 未披露 | 定期报告 | 2024-03-31 |
| 2024-01-31 | 204403.40 | 未披露 |
更多>>
From December 31 ,2022 to December 31 ,2023
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Sandoz employees as a result of the Sandoz spin-off
|
2023-12-31 |
| 2023-10-24 | 205546.05 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-07-18 | 206826.36 | 未披露 | 定期报告 | 2023-06-30 |
| 2023-04-25 | 209740.00 | 未披露 | 定期报告 | 2023-03-31 |
| 2023-02-01 | 211960.91 | 未披露 |
更多>>
From December 31 ,2021 to December 31 ,2022
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Alcon employees as a result of the Alcon spin-off
|
2022-12-31 |
| 2022-10-25 | 215098.04 | 未披露 | 定期报告 | 2022-09-30 |
| 2022-07-19 | 218278.86 | 未披露 | 定期报告 | 2022-06-30 |
| 2022-04-26 | 221258.49 | 未披露 | 定期报告 | 2022-03-31 |
| 2022-02-02 | 223493.99 | 未披露 |
更多>>
From January 1, 2021 to December 31, 2021
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
|
2021-12-31 |
| 2021-10-26 | 223709.15 | 未披露 | 定期报告 | 2021-09-30 |
| 2021-07-21 | 223673.90 | 未披露 |
更多>>
From January 1, 2021 to June 30, 2021
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Alcon employees as a result of the Alcon spin-off
|
2021-06-30 |
| 2021-04-27 | 224508.88 | 未披露 | 定期报告 | 2021-03-31 |
| 2021-01-26 | 225682.20 | 未披露 |
更多>>
From January 1, 2020 to December 31, 2020
Other share purchases
Exercise of options and employee transactions
Shares acquired to be canceled
Equity-based compensation
Shares delivered to Alcon employees as a result of the Alcon spin-off
|
2020-12-31 |
| 2020-10-27 | 227450.62 | 未披露 |
更多>>
From January 1, 2020 to September 30, 2020
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Alcon employees as a result of the Alcon spin-off
|
2020-09-30 |
| 2020-07-21 | 228897.96 | 未披露 | 定期报告 | 2020-06-30 |
| 2020-04-28 | 228867.82 | 未披露 |
更多>>
From January 1, 2020 to March 31, 2020
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Alcon employees as a result of the Alcon spin-off
|
2020-03-31 |
| 2020-01-29 | 226500.85 | 未披露 |
更多>>
From January 1, 2019 to December 31, 2019
Shares canceled for capital reduction
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Alcon employees
|
2019-12-31 |
| 2019-10-22 | 226460.81 | 未披露 |
更多>>
From January 1, 2019 to September 30, 2019
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
|
2019-09-30 |
| 2019-07-18 | 229176.54 | 未披露 |
更多>>
From January 1, 2019 to June 30, 2019
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
|
2019-06-30 |
| 2019-04-24 | 232282.79 | 未披露 |
更多>>
From January 1, 2019 to March 31, 2019
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
|
2019-03-31 |
| 2019-01-30 | 231117.14 | 未披露 |
更多>>
From January 1, 2018 to December 31, 2018
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Other share sales
Equity-based compensation
|
2018-12-31 |
| 2018-10-18 | 230997.27 | 未披露 |
更多>>
From January 1, 2018 to September 30, 2018
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
|
2018-09-30 |
| 2018-07-18 | 232174.03 | 未披露 |
更多>>
From January 1, 2018 to June 30, 2018
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
|
2018-06-30 |
| 2018-04-19 | 233080.34 | 未披露 |
更多>>
From January 1, 2018 to March 31, 2018
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
|
2018-03-31 |
| 2018-01-24 | 231745.65 | 未披露 |
更多>>
From January 1, 2017 to December 31, 2017
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
|
2017-12-31 |
| 2017-10-24 | 232733.98 | 未披露 |
更多>>
From January 1, 2017 to September 30, 2017
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
|
2017-09-30 |
| 2017-07-18 | 242230.00 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-01-25 | 237405.90 | 未披露 |
更多>>
From January 1, 2016 to December 31,2016
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
|
2016-12-31 |
| 2016-10-25 | 237551.74 | 未披露 |
更多>>
From January 1, 2016 to September 30,2016
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
|
2016-09-30 |
| 2016-07-19 | 238120.00 | 未披露 |
更多>>
From January 1, 2016 to June 30,2016
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
|
2016-06-30 |
| 2016-04-21 | 238127.65 | 未披露 |
更多>>
From December 31, 2015 to March 31,2016
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
|
2016-03-31 |
| 2016-01-27 | 237389.48 | 未披露 |
更多>>
from December 31, 2014 to December 31, 2015
Shares acquired to be held in Group Treasury
Shares acquired to be canceled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
|
2015-12-31 |
| 2015-10-27 | 239586.54 | 未披露 |
更多>>
from December 31, 2014 to September 30,2015
Shares acquired to be held in Group Treasury
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
|
2015-09-30 |
| 2015-07-21 | 241517.28 | 未披露 |
更多>>
from December 31, 2014 to June 30,2015
Shares acquired to be held in Group Treasury
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
|
2015-06-30 |
| 2015-04-23 | 242034.64 | 未披露 |
更多>>
from December 31, 2014 to March 31,2015
Shares acquired to be held in Group Treasury
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
|
2015-03-31 |
| 2015-01-27 | 239862.63 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Shares acquired to be held in Group Treasury
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
|
2014-12-31 |
| 2014-10-28 | 241871.66 | 未披露 |
更多>>
from January 1,2014 to September 30,2014
Shares acquired to be held in Group Treasury
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
|
2014-09-30 |
| 2014-01-29 | 242608.43 | 未披露 |
更多>>
from December 31,2012 to December 31,2013
Purchase of treasury shares
Increase in equity from exercise of options and employee transactions
Equity-based compensation
|
2013-12-31 |
| 2013-07-17 | 244741.55 | 未披露 |
更多>>
from January 1,2013 to June 30,2013
Shares acquired to be held in Group Treasury
Equity-based compensation
Other treasury share movements
|
2013-06-30 |
| 2013-01-23 | 242062.02 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Sale of treasury shares, net
Reduction of share capital
Equity-based compensation
|
2012-12-31 |
| 2012-04-24 | 242230.00 | 未披露 | 定期报告 | 2012-03-31 |
| 2012-01-25 | 240669.39 | 未披露 |
更多>>
from December 31, 2010 to December 31, 2011
Purchase of treasury shares, net
Equity-based compensation
Fair value of Novartis shares used to acquire outstanding non-controlling interests in Alcon, Inc.
|
2011-12-31 |
| 2011-07-19 | 242650.00 | 未披露 | 定期报告 | 2011-06-30 |
| 2011-04-19 | 228600.00 | 未披露 | 定期报告 | 2011-03-31 |
| 2011-01-27 | 228940.00 | 未披露 |
更多>>
from December 31, 2009 to December 31, 2010
Sale of treasury shares, net
Equity-based compensation
|
2010-12-31 |
| 2010-10-21 | 228960.00 | 未披露 | 定期报告 | 2010-09-30 |
| 2010-07-15 | 228750.00 | 未披露 | 定期报告 | 2010-06-30 |
| 2010-01-26 | 227435.34 | 未披露 |
更多>>
from December 31, 2008 to DECEMBER 31, 2009
Sale of treasury shares, net
Reduction of share capital
Equity-based compensation
|
2009-12-31 |
| 2009-01-28 | 226485.28 | 未披露 |
更多>>
from December 31, 2007 to DECEMBER 31, 2008
Reduction of share capital
|
2008-12-31 |
| 2008-01-28 | 226445.33 | 未披露 |
更多>>
from December 31, 2006 to DECEMBER 31, 2007
Acquisition of treasury shares, net
|
2007-12-31 |
| 2007-01-31 | 234823.15 | 未披露 |
更多>>
from December 31, 2005 to DECEMBER 31, 2006
Sales of treasury shares, net
Reduction in share capital
Transfers
|
2006-12-31 |
| 2006-01-30 | 233591.65 | 未披露 |
更多>>
from December 31, 2004 to DECEMBER 31, 2005
Acquisition of treasury shares, net
Reduction in share capital
Transfers
|
2005-12-31 |
| 2005-01-28 | 242681.01 | 未披露 |
更多>>
from December 31, 2003 to DECEMBER 31, 2004
Acquisition of treasury shares, net
Transfer to share premium
Reduction in share capital
|
2004-12-31 |
| 2004-01-30 | 246776.87 | 未披露 |
更多>>
from December 31, 2002 to DECEMBER 31, 2003
Acquisition of treasury shares, net
Redemption of call options on Novartis shares
Redemption of put options on Novartis shares
Reduction in share capital
|
2003-12-31 |
| 2003-02-24 | 247497.06 | 未披露 |
更多>>
from December 31, 2001 to DECEMBER 31, 2002
Acquisition of treasury shares, net
Reduction in share capital
|
2002-12-31 |
| 2002-03-18 | 254818.03 | 未披露 |
更多>>
from December 31, 2000 to DECEMBER 31, 2001
Acquisition of treasury shares, net
Issue of call options on Novartis shares
Issue of put options on Novartis shares
A 40-for-1 share split of the shares was affected on May 7, 2001 simultaneously with an ADS-to-share ratio change from 40-for-1 to 1-for-1.
|
2001-12-31 |
| 2001-04-11 | 6516.69 | 未披露 |
更多>>
from JANUARY 1, 2000 to DECEMBER 31, 2000
Transfer
Acquisition of treasury shares, net
|
2000-12-31 |
From December 31, 2023 to December 31, 2024
Shares acquired to be canceled
Other share purchases
Equity-based compensation plans, exercise of options and employee transactions
Other movements
From December 31 ,2022 to December 31 ,2023
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Sandoz employees as a result of the Sandoz spin-off
From December 31 ,2021 to December 31 ,2022
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Alcon employees as a result of the Alcon spin-off
From January 1, 2021 to December 31, 2021
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
From January 1, 2021 to June 30, 2021
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Alcon employees as a result of the Alcon spin-off
From January 1, 2020 to December 31, 2020
Other share purchases
Exercise of options and employee transactions
Shares acquired to be canceled
Equity-based compensation
Shares delivered to Alcon employees as a result of the Alcon spin-off
From January 1, 2020 to September 30, 2020
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Alcon employees as a result of the Alcon spin-off
From January 1, 2020 to March 31, 2020
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Alcon employees as a result of the Alcon spin-off
From January 1, 2019 to December 31, 2019
Shares canceled for capital reduction
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
Shares delivered to Alcon employees
From January 1, 2019 to September 30, 2019
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
From January 1, 2019 to June 30, 2019
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
From January 1, 2019 to March 31, 2019
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
From January 1, 2018 to December 31, 2018
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Other share sales
Equity-based compensation
From January 1, 2018 to September 30, 2018
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
From January 1, 2018 to June 30, 2018
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
From January 1, 2018 to March 31, 2018
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
From January 1, 2017 to December 31, 2017
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
From January 1, 2017 to September 30, 2017
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
From January 1, 2016 to December 31,2016
Shares acquired to be canceled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
From January 1, 2016 to September 30,2016
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
From January 1, 2016 to June 30,2016
Shares acquired to be cancelled
Other share purchases
Exercise of options and employee transactions
Equity-based compensation
From December 31, 2015 to March 31,2016
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
from December 31, 2014 to December 31, 2015
Shares acquired to be held in Group Treasury
Shares acquired to be canceled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
from December 31, 2014 to September 30,2015
Shares acquired to be held in Group Treasury
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
from December 31, 2014 to June 30,2015
Shares acquired to be held in Group Treasury
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
from December 31, 2014 to March 31,2015
Shares acquired to be held in Group Treasury
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
from December 31, 2013 to December 31, 2014
Shares acquired to be held in Group Treasury
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
from January 1,2014 to September 30,2014
Shares acquired to be held in Group Treasury
Shares acquired to be cancelled
Other share purchases
Increase in equity from exercise of options and employee transactions
Equity-based compensation
from December 31,2012 to December 31,2013
Purchase of treasury shares
Increase in equity from exercise of options and employee transactions
Equity-based compensation
from January 1,2013 to June 30,2013
Shares acquired to be held in Group Treasury
Equity-based compensation
Other treasury share movements
from December 31, 2011 to December 31, 2012
Sale of treasury shares, net
Reduction of share capital
Equity-based compensation
from December 31, 2010 to December 31, 2011
Purchase of treasury shares, net
Equity-based compensation
Fair value of Novartis shares used to acquire outstanding non-controlling interests in Alcon, Inc.
from December 31, 2009 to December 31, 2010
Sale of treasury shares, net
Equity-based compensation
from December 31, 2008 to DECEMBER 31, 2009
Sale of treasury shares, net
Reduction of share capital
Equity-based compensation
from December 31, 2007 to DECEMBER 31, 2008
Reduction of share capital
from December 31, 2006 to DECEMBER 31, 2007
Acquisition of treasury shares, net
from December 31, 2005 to DECEMBER 31, 2006
Sales of treasury shares, net
Reduction in share capital
Transfers
from December 31, 2004 to DECEMBER 31, 2005
Acquisition of treasury shares, net
Reduction in share capital
Transfers
from December 31, 2003 to DECEMBER 31, 2004
Acquisition of treasury shares, net
Transfer to share premium
Reduction in share capital
from December 31, 2002 to DECEMBER 31, 2003
Acquisition of treasury shares, net
Redemption of call options on Novartis shares
Redemption of put options on Novartis shares
Reduction in share capital
from December 31, 2001 to DECEMBER 31, 2002
Acquisition of treasury shares, net
Reduction in share capital
from December 31, 2000 to DECEMBER 31, 2001
Acquisition of treasury shares, net
Issue of call options on Novartis shares
Issue of put options on Novartis shares
A 40-for-1 share split of the shares was affected on May 7, 2001 simultaneously with an ADS-to-share ratio change from 40-for-1 to 1-for-1.
from JANUARY 1, 2000 to DECEMBER 31, 2000
Transfer
Acquisition of treasury shares, net